RocketTickers

Cara Therapeutics Announces Difelikefalin (KORSUVA™) Injection A

Long
NASDAQ:CARA   Cara Therapeutics, Inc.
CARA: Cara Therapeutics, Inc.
2022-01-10 08:00:00
Cara Therapeutics Announces Difelikefalin (KORSUVA™) Injection Achieves Positive Topline Results in Phase 3 Clinical Study in Japan for the Treatment of Pruritus in Hemodialysis Patients
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.